OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-NFYA antibodies

Anti-NFYA Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA314258 Rabbit polyclonal anti-NFYA antibody 100ul $325 In Stock
LC400893 NFYA HEK293T cell transient overexpression lysate (as WB positive control) 20ug $50 In Stock
Add to Shopping Cart

spacer
WB(1)

OriGene Data

ImmunogenThe antiserum was produced against synthesized peptide derived from internal of human NFYA.
Clone Name IsotypeIgG
Species ReactivityHuman, Mouse, Rat Concentration1mg/ml
Guaranteed Application *WB Suggested DilutionsWB: 1:500~1:3000, ELISA: 1:20000
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note NFYA antibody detects endogenous levels of total NFYA protein.

Reference Data

Target NameHomo sapiens nuclear transcription factor Y, alpha (NFYA), transcript variant 1
Alternative NameCBF-A; CBF-B; HAP2; NF-YA
Database LinkNP_002496
Entrez Gene 4800 Human
Entrez Gene 18044 Mouse
Entrez Gene 29508 Rat
Function
Related PathwayTranscription Factors Antigen processing and presentation

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Western blot analysis of extracts from 293 cells, HepG2 cells and COLO205 cells, using NFYA antibody.The lane on the right is treated with the synthesized peptide.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title